Johnson & Johnson coronavirus vaccine trial set to resume

The Johnson & Johnson coronavirus vaccine trial, paused earlier this month due to an unexplained illness in a participant, will resume very soon. An independent committee investigated the case of a man in the trial who suffered a stroke and concluded it was not related to the vaccine, according to two individuals familiar with the trial who spoke on the condition of anonymity.